Abstract
Laboratory testing is a key component in the management of psoriatic arthritis (PsA) patients. Baseline laboratory tests have a prognostic value, aid the assessment of a patient’s general health thereby guiding treatment choices, and in the long-term help monitor disease activity, response to, and tolerability of pharmacological therapies. Laboratory testing complements the clinical suspicion of PsA raised by history, examination and imaging. Whilst there is no pathognomic diagnostic laboratory test specifi c to PsA, several tests help differentiate PsA from other forms of arthritis.
Original language | English |
---|---|
Title of host publication | Psoriatic Arthritis and Psoriasis |
Subtitle of host publication | Pathology and Clinical Aspects |
Editors | A. Adebajo, W-H. Boehncke, D. D. Gladman, P. J. Mease |
Place of Publication | London, U. K. |
Publisher | Springer International Publishing |
Pages | 227-240 |
Number of pages | 14 |
Volume | Part V1 |
ISBN (Electronic) | 9783319195308 |
ISBN (Print) | 9783319195292 |
DOIs | |
Publication status | Published - 12 Jan 2016 |
Keywords
- Anti-citrullinated cyclical peptide antibodies
- Biomarkers
- C-reactive protein
- Genetic testing
- HLA-B27
- Lefl unomide
- Methotrexate
- Psoriatic arthritis
- Rheumatoid factor
- Sulfasalazine